FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104802 [Registered on: 25/02/2026] Trial Registered Prospectively
Last Modified On: 23/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparative effect of Rasanjanadi Yoga (hypothetical) and Pramehnashak Yoga on type 2 Diabetes Mellitus w.s.r. Prameha 
Scientific Title of Study   A Randomised Comparative Clinical Study to Evaluate The Efficacy of Rasanjanadi Yoga (Hypothetical) and Pramehnashak Yoga on Type 2 Diabetes Mellitus W.S.R. Prameha 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Khushwant Joshi 
Designation  Ph.D. Scholar 
Affiliation  Keshav Ayurvedic Medical College and Hospital, Aklera, Jhalawar 
Address  Department of Kayachikitsa, Keshav Ayurvedic Medical College and Hospital, Aklera, Jhalawar

Jhalawar
RAJASTHAN
326033
India 
Phone  9414269342  
Fax    
Email  dr.khushwantjoshi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Ravi Sharma 
Designation  Professor and Head of Department 
Affiliation  Madan Mohan Malviya Govt. Ayurveda College, Udaipur 
Address  PG Department of Kayachikitsa, Madan Mohan Malviya Govt. Ayurveda College, Udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  9414419259  
Fax    
Email  face.udr@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Ravi Sharma 
Designation  Professor and Head of Department 
Affiliation  Madan Mohan Malviya Government Ayurveda College, Udaipur 
Address  PG Department of Kayachikitsa, Madan Mohan Malviya Government Ayurveda College, Udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  9414419259  
Fax    
Email  face.udr@gmail.com  
 
Source of Monetary or Material Support  
Keshav Ayurvedic Medical College and Hospital, Aklera, Jhalawar, Rajasthan 326033 
 
Primary Sponsor  
Name  Dr Khushwant Joshi 
Address  Department of Kayachikitsa, Keshav Ayurveda Medical College and Hospital, Aklera, Jhalawar, Rajasthan 326033 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Khushwant Joshi  Keshav Ayurvedic Medical College and Hospital, Aklera, Jhalawar  Department of Kayachikitsa, Keshav Ayurvedic Medical College and Hospital, Aklera, Jhalawar
Jhalawar
RAJASTHAN 
9414269342

dr.khushwantjoshi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Madan Mohan Malviya Government Ayurveda College Udaipur Rajasthan  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: PRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Rasanjanadi Yoga, Reference: NA, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: Hypothetical
2Comparator ArmDrugClassical(1) Medicine Name: Pramehanashak Yoga, Reference: Charak Samhita, Chikitsa Sthan, Chapter 6, Shloka no. 26, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: Charak Samhita, Chikitsa Sthan, Chapter 6, Shloka no. 26
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Patients which comes under criteria of diagnosis.
2. Patients who agree for the trial and fill the consent form.
 
 
ExclusionCriteria 
Details  1. Patients below the age of 30 years and above 70 years.
2. Pregnant and lactating females.
3. Life threatening conditions [e.g.. Cancer]
4. Type-1 Diabetes mellitus
5. Secondary diabetes i.e., Pancreatitis
6. Presence of any other serious medical condition that may interfere with study participation. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in subjective and objective parameter.  90 days 
 
Secondary Outcome  
Outcome  TimePoints 
Improve the Quality of life & wellbeing   90 days 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

THIS STUDY IS A PROSPECTIVE, RANDOMIZED, OPEN-LABEL COMPARATIVE CLINICAL TRIAL DESIGNED TO EVALUATE THE EFFICACY AND SAFETY OF RASANJANADI YOGA IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS, CORRELATED WITH PRAMEHA IN AYURVEDIC LITERATURE. A TOTAL OF 100 DIAGNOSED PATIENTS ARE RANDOMLY ALLOCATED INTO TWO EQUAL GROUPS, WITH GROUP A RECEIVING RASANJANADI YOGA AND GROUP B RECEIVING PRAMEHANASHAK YOGA AS THE CONTROL INTERVENTION. THE PRIMARY OUTCOME MEASURES FOCUS ON IMPROVEMENT IN GLYCEMIC CONTROL AND CLINICAL SYMPTOMS OF DIABETES, WHILE SECONDARY OUTCOMES ASSESS SAFETY THROUGH MONITORING ADVERSE DRUG REACTIONS AND THE SUSTAINABILITY OF THERAPEUTIC EFFECTS AFTER TREATMENT COMPLETION. BY INTEGRATING AYURVEDIC PRINCIPLES WITH MODERN CLINICAL ENDPOINTS, THE STUDY AIMS TO SCIENTIFICALLY VALIDATE THE THERAPEUTIC POTENTIAL OF RASANJANADI YOGA AND ESTABLISH A CONCEPTUAL BRIDGE BETWEEN AYURVEDIC MANAGEMENT OF PRAMEHA AND CONTEMPORARY UNDERSTANDING OF DIABETES PATHOPHYSIOLOGY.

 
Close